0001047469-09-002743 Sample Contracts

PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT
Change of Control Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations

This Amended and Restated Change of Control Agreement (this “Agreement”), dated as of February 24, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and CHENI KWOK (the “Executive”) to reflect amendments made in December, 2008.

Sample 1Sample 2Sample 3See All (28)
AutoNDA by SimpleDocs
PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED KEY EXECUTIVE SEVERANCE AGREEMENT
Key Executive Severance Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations

This Amended and Restated Key Executive Severance Agreement (this “Agreement”), dated as of February 24, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10 hereof, the “Company”), and CHENI KWOK (the “Executive”) to reflect amendments made in December, 2008.

Sample 1Sample 2Sample 3See All (23)
PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENT
Change of Control Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations • California

This Change of Control Agreement (this “Agreement”), dated as of February 18, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and Greg Weaver (the “Executive”).

Sample 1Sample 2Sample 3See All (4)
COMMERCIAL SUPPLY AGREEMENT
Commercial Supply Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations

This Commercial Supply Agreement (this “Agreement”) is entered into by and between Baxter Oncology GmbH, with an address at Kantstrasse 2, 33790 Halle / Westphalia, Germany (“BAXTER”) and Poniard Pharmaceuticals, Inc., a Washington corporation, having offices at 7000 Shoreline Court, Suite 270, South San Francisco, CA 94080 (“PONIARD”).

Sample 1
PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT (CEO)
Change of Control Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations

This Amended and Restated Change of Control Agreement (CEO) (this “Agreement”), dated as of February 24, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (formerly known as NeoRx Corporation and as supplemented by Section 13 hereof, the “Company”), and GERALD MCMAHON (the “Executive”) to reflect amendments made in December, 2008.

Sample 1
PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED KEY EMPLOYEE SEVERANCE AGREEMENT
Key Employee Severance Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations

This Amended and Restated Key Employee Severance Agreement (this “Agreement”), dated as of February 24, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10 hereof, the “Company”), and Michael K. Jackson (the “Employee”) to reflect amendments made in December, 2008.

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!